We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+15.6%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$8.4B
AUM Growth
+$1.66B
Cap. Flow
+$1.33B
Cap. Flow %
15.85%
Top 10 Hldgs %
61.33%
Holding
510
New
182
Increased
113
Reduced
52
Closed
146

Top Buys

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$79.7M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$74.4M
3
KVUE icon
Kenvue
KVUE
+$65.3M
4
ELF icon
e.l.f. Beauty
ELF
+$51.7M
5
GSK icon
GSK
GSK
+$46.6M

Top Sells

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$96.3M
2
EXAS
Exact Sciences
EXAS
+$56.4M
3
PTCT icon
PTC Therapeutics
PTCT
+$34.5M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$28M
5
MDB icon
MongoDB
MDB
+$23M

Sector Composition

Rank Sector Weight
1 Healthcare 32.56%
2 Technology 5.44%
3 Consumer Discretionary 5.13%
4 Consumer Staples 2.69%
5 Communication Services 1.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNGX icon
476
Soligenix
SNGX
$5.81M
– –
-708,000
Closed -$821K
SPOT icon
477
Spotify
SPOT
$100B
– –
-2,250
Closed -$1.57M
SU icon
478
Suncor Energy
SU
$70.3B
– –
-4,877
Closed -$204K
SXT icon
479
Sensient Technologies
SXT
$5.53B
– –
-67,630
Closed -$6.35M
TFC icon
480
Truist Financial
TFC
$64B
– –
-6,544
Closed -$299K
THG icon
481
Hanover Insurance
THG
$7.98B
– –
-2,348
Closed -$426K
TKO icon
482
TKO Group
TKO
$13.6B
– –
-6,026
Closed -$1.22M
TOON icon
483
Kartoon Studios
TOON
$34.9M
– –
-520,606
Closed -$384K
TTWO icon
484
Take-Two Interactive
TTWO
$46.1B
– –
-3,492
Closed -$902K
TXN icon
485
Texas Instruments
TXN
$261B
– –
-1,191
Closed -$219K
TYL icon
486
Tyler Technologies
TYL
$12.8B
– –
-1,397
Closed -$731K
UMBF icon
487
UMB Financial
UMBF
$11.1B
– –
-7,580
Closed -$897K
UPS icon
488
United Parcel Service
UPS
$88.9B
– –
-2,712
Closed -$227K
USFD icon
489
US Foods
USFD
$24B
– –
-5,626
Closed -$431K
VIRT icon
490
Virtu Financial
VIRT
$4.93B
– –
-8,468
Closed -$301K
VNRX icon
491
VolitionRx Ltd
VNRX
$9.34M
– –
-469,021
Closed -$6.37M
VRTX icon
492
Vertex Pharmaceuticals
VRTX
$126B
– –
-40,239
Closed -$15.8M
WAB icon
493
Wabtec
WAB
$49.3B
– –
-1,511
Closed -$303K
WATT icon
494
Energous
WATT
$102M
– –
-155,636
Closed -$1.2M
WIX icon
495
WIX.com
WIX
$2.52B
– –
-5,136
Closed -$912K
WMB icon
496
Williams Companies
WMB
$86.1B
– –
-3,689
Closed -$234K
WSBC icon
497
WesBanco
WSBC
$4B
– –
-6,924
Closed -$221K
XLK icon
498
State Street Technology Select Sector SPDR ETF
XLK
$124B
– –
-2,568
Closed -$362K
XRT icon
499
State Street SPDR S&P Retail ETF
XRT
$327M
– –
-9,262
Closed -$798K
RDDT icon
500
CALL
Reddit
RDDT
$31.1B
– –
-1,500
Closed -$345K
17 18 19
20
21

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Armistice Capital held 510 positions worth $8.4B, up 25% from $6.74B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Armistice Capital deployed $1.33B of net new capital in Q4 2025, opening 182 new positions and adding to 113 existing holdings. Its largest new stake was Kenvue: 3,992,196 shares worth $68.9M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Travere Therapeutics, an estimated $96.3M trimmed.

  • Armistice Capital's largest Q4 2025 buy was Kenvue: 3,992,196 shares worth $68.9M.
  • Armistice Capital added most to Agios Pharmaceuticals in Q4 2025, an estimated $79.7M increase.
  • Armistice Capital's biggest Q4 2025 reduction was Travere Therapeutics, cutting an estimated $96.3M.
  • Armistice Capital fully exited Exact Sciences in Q4 2025, selling an estimated $56.4M.
  • Armistice Capital's ten largest holdings make up 61% of its $8.4B portfolio in Q4 2025.
  • Armistice Capital opened 182 new positions and closed 146 in Q4 2025.
  • Armistice Capital's portfolio value rose 25% quarter-over-quarter to $8.4B.

Based on Armistice Capital's 13F filing for Q4 2025, filed 17 Feb 2026.